Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Candel Therapeutics Inc., 3 years.
Candel Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 21, 2025 | Candel Therapeutics Inc. | Sold back to the company | −10,582 | $12.02 | $127,196 |
| Feb 21, 2025 | Candel Therapeutics Inc. | Sold back to the company | −10,583 | $12.02 | $127,208 |
| Feb 10, 2025 | Candel Therapeutics Inc. | Sold back to the company | −31,335 | $8.61 | $269,794 |
| Dec 12, 2024 | Candel Therapeutics Inc. | Sold back to the company | −200,000 | $10.04 | $2,008,000 |
| Dec 12, 2024 | Candel Therapeutics Inc. | Sold back to the company | −200,000 | $10.04 | $2,008,000 |
| Dec 11, 2024 | Candel Therapeutics Inc. | Sold back to the company | −200,000 | $8.53 | $1,706,000 |
| Dec 11, 2024 | Candel Therapeutics Inc. | Sold back to the company | −200,000 | $8.53 | $1,706,000 |
| Oct 15, 2024 | Candel Therapeutics Inc. | Open-market sale | −10,412 | $6.03 | $62,784 |
| Oct 14, 2024 | Candel Therapeutics Inc. | Open-market sale | −15,000 | $6.02 | $90,300 |
| Oct 11, 2024 | Candel Therapeutics Inc. | Open-market sale | −15,000 | $6.05 | $90,750 |
| Oct 3, 2024 | Candel Therapeutics Inc. | Open-market sale | −1,800 | $6.85 | $12,330 |
| Oct 2, 2024 | Candel Therapeutics Inc. | Open-market sale | −26,988 | $6.92 | $186,757 |
| Oct 1, 2024 | Candel Therapeutics Inc. | Open-market sale | +6,214 | $7.01 | $43,560 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.